Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $5 | $10 | $5 | $4 |
| % Growth | -44.7% | 103.2% | 34.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $5 | $10 | $4 | $3 |
| % Margin | 100% | 100% | 91.7% | 89% |
| R&D Expenses | $12 | $16 | $9 | $8 |
| G&A Expenses | $2 | $2 | $2 | $1 |
| SG&A Expenses | $8 | $7 | $7 | $5 |
| Sales & Mktg Exp. | $6 | $6 | $5 | $3 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $20 | $23 | $15 | $13 |
| Operating Income | -$15 | -$13 | -$11 | -$9 |
| % Margin | -272% | -129.3% | -216.4% | -250.9% |
| Other Income/Exp. Net | $0 | -$10 | -$0 | -$0 |
| Pre-Tax Income | -$15 | -$23 | -$11 | -$9 |
| Tax Expense | $0 | -$10 | $0 | $0 |
| Net Income | -$15 | -$13 | -$11 | -$9 |
| % Margin | -268.4% | -131.3% | -220% | -260.9% |
| EPS | -0.005 | -0.006 | -0.006 | -0.005 |
| % Growth | 18.3% | -5.3% | -7.5% | – |
| EPS Diluted | -0.005 | -0.006 | -0.006 | -0.005 |
| Weighted Avg Shares Out | 2,980 | 2,174 | 1,876 | 1,788 |
| Weighted Avg Shares Out Dil | 2,980 | 2,174 | 1,876 | 1,788 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$15 | -$13 | -$15 | -$13 |
| % Margin | -273.5% | -130.1% | -311.3% | -349.4% |